Emerging role of biomarkers for cardiovascular risk assessment in T2DM and optimisation of cardioprotective treatment: current evidence and future trends

September 15, 2022 | 6:00 PM CET | USA

After watching this webinar, participants will understand: the role of biomarkers in the risk assessment of patients with heart failure and diabetes, as well as those with diabetes who are at increased risk of developing heart failure.
Register Now


Introduction to Biotech


Medical Tech-BioTech Day

December 07, 2022 | 10:00 AM CET

The medical technology industry becomes an essentiel component of the whole care pathway. Advanced technologies such as Smart connectivity, Health Sensors, AI/ML in decision making, robotics, VR/AR/XR are not only improving medical devices but also are opening new perspectives for the care of human beings. According to « Absolute Markets Insights ». Global medical technology market was valued at US$ 565,52 billion in 2018 and is expected to reach 2324.34 billion by 2027, growing at an estimated CAGR of 17.1% over the forecast period. The segments that we will develop in this conference are about the use of solutions in the field of of mHealth, eHealth, telemedicine, telematics / telemetry, medical information systems / software, Medical Apps, portable diagnostics, wearables and augmenting human features and well beings.
Register Now

Devices and tools in percutaneous coronary interventions - IC Core Curriculum 4

September 14, 2022 | 6:00 PM CET

After watching this webinar, participants will know about: classification of CAD lesion subsets and their recommended invasive treatment strategies; evidence for use of interventional devices in the treatment of coronary artery disease; and current recommendations for peri- and post-procedural antithrombotic therapy in the treatment of coronary artery disease.
Register Now

Percutaneous interventions in patients with coronary artery disease and specific clinical conditions

November 09, 2022 |

After watching this webinar, participants will understand: indications for percutaneous treatment of cardiogenic shock; evidence and limitations for interventional CAD treatment of diabetic patients; diagnostic and therapeutic approaches to CAD in patients with advanced kidney disease; and indications and strategies for performing CHIP.
Register Now

How is cardiac troponin released from cardiomyocyte ?

September 21, 2022 | 6:00 PM CET

After watching this webinar, participants will be able to: understand the evolving concept and several hypotheses on how cTn is released from cardiomyocyte; understand that in most settings cTn release indicates irreversible cardiomyocyte injury and cell death; and identify settings in which cTn release may also indicate reversible injury.
Register Now